Polyrizon Ltd.: Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform
Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...
Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform
Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...
The Manila Times7h
Meridianbet Expands B2B Operations into Nigeria, Entering a Regulated $2 Billion Betting Market
The official launch of Meridianbet.ng marks a strategic expansion into a market worth over $2 billion, according to the ...
Polyrizon launches preclinical studies for intranasal naloxone
Polyrizon (PLRZ) previously announced the initiation of preclinical studies for intranasal Naloxone, a life-saving opioid overdose treatment.
Polyrizon Ltd.: Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform
Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...
The Manila Times3d
WNBA champ Sabrina Ionescu in Manila for skills camp
WNBA champion and Olympic medalist Sabrina Ionescu graced the Nike Courtyard to impart invaluable lessons to Filipino hoopers ...